Clinical Trial Update: Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NKTR-102 in metastatic or locally advanced ovarian cancer has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• NKTR-102

Snippet

Sponsor: Nektar Therapeutics | Conditions: Tumor, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-06-14